MDAI Stock Analysis: Buy, Sell, or Hold?
MDAI - Spectral AI, Inc. Class A Common Stock
$1.61
0.06 (3.87%)
▲
5d:
-1.83%
30d:
-10.06%
90d:
-25.12%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When MDAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MDAI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: MDAI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MDAI is currently trading at $1.61, which is considered slightly low relative to its 30-day fair value range of $1.60 to $1.75.
Technical Outlook: Technically, MDAI is showing sideways momentum. Immediate support is located at $1.50, while resistance sits at $1.70. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: MDAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.12 (+218.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MDAI is showing sideways momentum. Immediate support is located at $1.50, while resistance sits at $1.70. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: MDAI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.12 (+218.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.60 -
$1.75
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 218.3% below Wall St target ($5.12)
Trading Range Analysis
30-Day Trading Range
$1.60 -
$1.75
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.70
Current Trend
Sideways
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.54
Wall Street Target
$5.13
(+218.3%)
Revenue Growth (YoY)
-40.5%
Profit Margin
-82.0%
Share & Embed Analysis
Last updated: August 04, 2026 5:10 AM ET
Data refreshes hourly during market hours. Next update: 6:10 AM
Data refreshes hourly during market hours. Next update: 6:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |